Antibacterial activity of cystobactamid A-ring analogs, given as minimal inhibitory concentrations (MICs) in μg mL−1, and inhibitory activity against DNA gyrase in μMe.
Compound | MIC [μg mL−1] | E. coli gyrase IC50 [μM] | |||||||
---|---|---|---|---|---|---|---|---|---|
E. coli ΔtolCa | E. coli WTb | P. ae. ΔmexABa | P. ae. WTc | S. aureus d | |||||
R | |||||||||
o | m | p | |||||||
Reference 4 | H | H | NO 2 | 0.125 | 1 | 1 | >64 | 1 | 0.11 |
14 | H | H | NHAc | 0.06 | 16 | >64 | >64 | 64 | nd |
15 | H | H | H | 0.5 | >64 | 2 | >64 | >64 | 4.0 |
16 | H | H | F | 0.5 | 0.5 | 2 | >64 | 2 | nd |
17 | H | H | NH2 | 32 | 2 | 4 | >64 | >64 | 26.8 |
18 | H | NO2 | H | 0.25 | >64 | 0.5 | >64 | >64 | 2.2 |
19 | H | NH2 | H | 2 | 32 | 4 | >64 | >64 | nd |
20 | NO2 | H | H | 2 | 8 | 16 | >64 | >64 | nd |
21 | H | H | NHCONH2 | ≤0.03 | 0.5 | 4 | >64 | 64 | 8.7 |
22 | H | H | CN | 0.06 | 0.5 | 0.25 | 2 | 0.25 | 0.08 |
23 | H | H | CF3 | ≤0.03 | 0.5 | 64 | >64 | 16–32 | nd |
24 | H | H | >64 | 0.5 | >64 | >64 | >64 | 2.5 | |
25 | OH | i-PrO | NO2 | >64 | >64 | >64 | >64 | >64 | >50 |
26 | OH | i-PrO | NH2 | 0.01 | 2 | 2–4 | 32 | >64 | 50 |
27 | H | H | SO2CH3 | ≤0.03 | 2 | 4 | >64 | >64 | nd |
28 | 8 | 16 | >64 | >64 | >64 | 16 | |||
29 | ≤0.03 | ≤0.03 | 1 | >64 | 1 | 1.4 | |||
30 | ≤0.03 | ≤0.03 | 1 | >64 | 64 | 0.5 | |||
31 | ≤0.03 | ≤0.03 | 0.25 | 0.5 | ≤0.03 | 0.9 | |||
32 | ≤0.03 | ≤0.03 | 0.25 | 0.5 | 0.25 | 0.5 | |||
33 | ≤0.03 | 0.06 | 1 | >64 | 4 | nd | |||
34 | ≤0.03 | ≤0.03 | 0.5 | >64 | 64 | 0.7 | |||
35 | >64 | >64 | >64 | >64 | >64 | 3.6 | |||
36 | 0.5 | 0.25 | >64 | >64 | >64 | 0.3 |
Strain provided by collaborators, see ESI.
DSM-1116.
PA14.
ATCC29213.
nd = not determined, P. ae. = P. aeruginosa.